L’Oréal is contending with a group of six class action lawsuits related to their acne treatments, including CeraVe, which are accused of containing benzene—a known carcinogen. Plaintiffs argue that the levels of benzene in these products greatly surpass what is […]
L’Oréal Faces Class Action Over Benzene in Acne Products Read More »
Stryker has solidified a definitive agreement to acquire Inari Medical for $80 per share, a substantial markup valuing the transaction at $4.9 billion. Prior to the announcement, Inari Medical’s shares were trading at around $48. Endorsed by both Stryker’s board
Stryker Agrees to Acquire Inari Medical in $4.9 Billion Transaction Read More »
Medtronic (NYSE: MDT) has announced that its Harmony transcatheter pulmonary valve (TPV) system has secured CE mark approval. According to Children’s HeartLink, a nonprofit from Minneapolis, approximately 1.3 million children worldwide are born annually with congenital heart defects. The Harmony
CE Mark Granted to Medtronic for Harmony Transcatheter Pulmonary Valve Read More »
NanoVibronix (Nasdaq:NAOV) has announced the successful completion of the initial phase in a randomized controlled trial for its UroShield device. This study was conducted by researchers at the University of Michigan. UroShield, a compact ultrasonic therapeutic tool, implements innovative low-intensity
NanoVibronix Wraps Up Initial UroShield Pilot Study Read More »
Microbot Medical (Nasdaq: MBOT) has disclosed that it has entered into formal agreements for the procurement and sale of common stock, garnering $7 million in proceeds. The offering comprises over 4 million shares of common stock at a price of
Outset Medical (Nasdaq: OM) confirmed that it has finalized a securities purchase agreement valued at approximately $168.8 million. This agreement involves a private offering of 843,908 shares of Series A non-voting convertible preferred stock priced at $200 each. Following shareholder
Outset Medical Secures $169 Million in New Funding Read More »
Integra Lifesciences has been issued a warning letter by the FDA regarding quality control problems identified at multiple locations. The disclosure came through an SEC filing, where it was revealed that the letter, received on December 19, 2024, outlines deficiencies
FDA Issues Warning to Integra Lifesciences Over Quality Concerns at Multiple Sites Read More »
Synchron has announced an enhanced partnership with Team Gleason aimed at increasing awareness for its brain-computer interface (BCI) community. Team Gleason, established by former New Orleans Saints player Steve Gleason following his ALS diagnosis in 2011, is a foundation devoted
Synchron and Team Gleason Partner to Promote BCI Community Awareness Read More »
Hologic (Nasdaq: HOLX) has officially announced the completion of its $350 million acquisition of Gynesonics. The Marlborough, Massachusetts-based medical technology company first revealed its plan to purchase Gynesonics in October. Gynesonics is known for creating innovative, minimally invasive medical devices
Hologic Finalizes Purchase of Gynesonics Read More »
Wellumio has today revealed the establishment of a new branch in California, marking an expansion of its presence in the United States. Originating from New Zealand, the company specializes in cutting-edge stroke detection technologies, particularly with its Axana device. This
Stroke Detection Innovator Wellumio Expands California Operations Read More »